Switzerland - Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes
Since 2014, Switzerland Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes increased 4.6% year on year. In 2019, the country was ranked number 22 comparing other countries in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes with €0.8 Per Capita. Switzerland is overtaken by Netherlands, which was ranked number 21 at €1 Per Capita and is followed by Lithuania with €0.5 Per Capita. Ireland ranked the highest with €447.21 Per Capita in 2019, that is a fall of 0.8% versus 2018. Italy, Norway and Sweden respectively ranked number 2, 3 and 4 in this ranking. Poland recorded the best 5 years average growth at +106.8% per year, while Bulgaria witnessed the worst performance at -12.9% per year.
Loading...
Date | Euros Per Capita |
---|---|
2019 | 0.80 |
2018 | 0.77 |
2017 | 0.80 |
2016 | 0.84 |
2015 | 0.78 |
How does Switzerland rank in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes?
# | 29 Countries | Euros Per Capita | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
Ireland
|
447.21 | 2019 | -0.8 % | +2.1 % | View data | |
2 |
#2
Italy
|
284.66 | 2019 | +0.3 % | +2.7 % | View data | |
21 |
#21
Netherlands
|
1.00 | 2019 | +1.0 % | -0.6 % | View data | |
22 |
#22
Switzerland
|
0.80 | 2019 | +3.9 % | +4.6 % | View data | |
23 |
#23
Lithuania
|
0.50 | 2019 | -3.9 % | +17.8 % | View data |